Navigation Links
Discovery could help to develop drugs for organ transplant and cancer patients
Date:4/13/2012

MAYWOOD, Ill. -- Loyola researchers are reporting surprising findings about a molecule that helps ramp up the immune system in some cases and suppress it in others.

The finding eventually could lead to new drugs to regulate the immune system by, for example, revving it up to attack tumor cells or tamping it down to prevent the rejection of transplanted organs.

The study is published online ahead of print in the Journal of Immunology. Senior author is Makio Iwashima, PhD, an associate professor in the Department of Microbiology & Immunology of Loyola University Chicago Stritch School of Medicine. Co-authors are Robert Love, MD, a professor in the Departments of Thoracic & Cardiovascular Surgery and Microbiology & Immunology and one of the world's leading lung transplant surgeons, and first author Mariko Takami, PhD, of the Department of Microbiology & Immunology.

The immune system relies on a balancing act between two types of cells. Effector cells attack tumor cells and cells infected by viruses or bacteria. Regulatory cells suppress the immune system so that it does not attack healthy tissue. If effector cells are too active, an individual can suffer autoimmune disorders such as lupus, Type 1 diabetes and multiple sclerosis. But if regulatory cells are too active, the immune system will not be aggressive enough to protect the individual from germs and cancer.

The study involved an immune system molecule called transforming growth factor beta (TGF-β). TGF-β is known to be a powerful regulator of the immune response -- generally suppressing the strength of the response. In this study, however, Loyola researchers demonstrated that TGF-β can amplify the immune response and result in a more effective targeted response under specific conditions.

"TGF-β is a double-edged sword," Iwashima said. "It augments immune system reactions but does not determine what direction they will take. Depending on conditions, these reactions can either activate or suppress the immune system."

The study involved mouse cells grown ex vivo in laboratory dishes. The next steps will be to study TGF-β in human cells and in animal models. Understanding the dual role of TGF-β could help in the development of drugs to either activate or suppress the immune system, as needed, Iwashima said.


'/>"/>

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Source:Eurekalert

Related medicine news :

1. Washingtons Life Sciences Discovery Fund awards commercialization grants
2. Scientist awarded $1 million grant to develop tools for hepatitis C treatment discovery
3. New discovery of proteins involved in positioning muscular nuclei
4. Cell signaling discovery provides new hope for blood disorders
5. Gene mutation discovery sparks hope for effective endometriosis screening
6. Discovery predicts patient sensitivity to important drug target in deadly brain cancer
7. Discovery of new vaccine approach for treatment of cancer
8. Zebrafish may help speed drug discovery
9. Unexpected discovery opens up new opportunities for targeting cancer
10. Journal names discovery that HIV treatment can prevent spread breakthrough of the year
11. Salk discovery may lead to safer treatments for asthma, allergies and arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2020)... ... August 31, 2020 , ... In an effort to ... is donating 10 percent of each hotel room booked with a special new ... Chicagoland & Northwest Indiana (RMHC-CNI) , effective immediately. Donations will be applied to ...
(Date:8/31/2020)... ... August 31, 2020 , ... Bonde Innovations, LLC, a venture-backed ... heart failure, today announced that the company has been awarded a Phase 1 ... National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH). ...
(Date:8/28/2020)... ... August 28, 2020 , ... Ernst & Young LLP (EY ... Entrepreneur Of The Year® 2020 Florida Award finalist. Now in its 34th year, ... innovation, growth and prosperity as they build and sustain successful businesses that transform ...
(Date:8/28/2020)... ... August 28, 2020 , ... The 15 scholarships being ... Health & Wellness mobile app and web-portal. NCPCV received a 2020 grant from ... grants each year to organizations, such as Destination Imagination, which support and advance ...
(Date:8/28/2020)... ... ... Integrated Viral Protection (IVP Air) today announced that the True ... Mobile Biodefense Indoor Air Protection System that is the first system designed and proven ... equipped with the filtration system on September 8th. , The IVP Air S1 ...
Breaking Medicine News(10 mins):
(Date:8/28/2020)... SAN ANTONIO (PRWEB) , ... August 28, 2020 ... ... company and operator of primary care medical centers in Florida and San Antonio ... ambassador for its South Texas medical centers. , In this capacity he will ...
(Date:8/27/2020)... (PRWEB) , ... August 27, 2020 , ... The flu season is right round the ... get well equipped with all the necessary measures before it begins to harbor its effects ... increasing, and it is leaving a huge impact on our lives. Hence it has become ...
(Date:8/26/2020)... Ill. (PRWEB) , ... August 26, 2020 , ... ... infographic: How Chiropractic Care Helps Sports Injuries. The infographic breaks down ways that ... a quicker, healthier recovery. , According to ScripHessco “Athletes have an unusual amount ...
Breaking Medicine Technology: